About

Built on Advocacy
Grown Through Access

Our story starts with patients.

TOPCAT BIO

Where We Started

TOPCAT BIO is a family-owned, patient-first company founded by Eric Toppy in 2020. We answer only to our clients, unlike firms that are private-equity owned and chasing revenue targets.

Eric Toppy, Founder and President of TOPCAT BIO
  1. 2016

    The journey started in 2016, when Toppy created TBI ANGEL, a nonprofit dedicated to helping TBI and ALS patients with all of their care needs, from diagnosis to end of life. Now in its 10th year, TBI ANGEL has provided more than $100,000 in services to patients in need.

  2. 2019–2020

    From 2019 to 2020, as Vice President, Patient Engagement and Market Access at a start-up gene therapy company, Toppy was disheartened by his conversations with families affected by Krabbe disease. They told him again and again that they didn't know about newborn screening, treatment centers of excellence or even where to turn for clinical trials.

  3. 2020

    TOPCAT BIO was born in February 2020 to meet that unmet need through education. Our first project was the KrabbeConnect patient journey map, built with KrabbeConnect's founders to close those gaps for the Krabbe community. The maps have been presented at WORLDSymposium, Global Genes' RARE Advocacy Summit and the NORD Rare Diseases & Orphan Products Breakthrough Summit, and they are still used by providers and Krabbe families today.

  4. Alongside his patient work, Toppy spent 25 years building and leading market access departments at the VP level for established and growing biotech companies. Before that, he helped build out a regional health plan.

  5. 2025

    In 2025, our first client asked TOPCAT BIO to build and support the market access and patient support function for the 2026 launch of an oncology product and a retina product. TOPCAT BIO built the strategy and the entire access support platform for both launches. Several more biotech clients have followed.

  6. Today

    What began as patient education has grown into a full access company. Today TOPCAT BIO brings strategic consulting, experienced field teams, patient support services and copay programs to small and mid-size biotech companies, along with our dedicated Oncology and Rare divisions. We still build patient journey maps free of charge for rare disease patient organizations, including one now in progress for the ALS community.

Where We've Grown

Since 2020, TOPCAT BIO has grown into a boutique firm purpose-built for small to mid-size biotech companies, the businesses too often priced out of enterprise-scale market access consultancies. We built TOPCAT BIO to make expert-level market access and patient support achievable at a price point that makes sense for growing companies.

TOPCAT BIO

What Makes Us Different

  1. We stand behind our strategy with delivery. Where other consulting firms hand off a recommendation, we build the product or team that puts it into action.

  2. Our people bring market access and patient support experience found nowhere else in the industry.

  3. We work at a scale and price point built for small to mid-size biotech, not just the largest players.